ID   AHH-1 TK+/- h1B1/OR
AC   CVCL_C7JT
SY   h1B1/OR
DR   Wikidata; Q117704458
RX   PubMed=9106248;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2597; CYP1B1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU61 ! AHH-1 TK+/-
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 6
//
RX   PubMed=9106248; DOI=10.1093/mutage/12.2.83;
RA   Crespi C.L., Penman B.W., Steimel D.T., Smith T., Yang C.-S.,
RA   Sutter T.R.;
RT   "Development of a human lymphoblastoid cell line constitutively
RT   expressing human CYP1B1 cDNA: substrate specificity with model
RT   substrates and promutagens.";
RL   Mutagenesis 12:83-89(1997).
//